SM, F., F, R., G, E., V, M., E, B., C, B., . . . P, F. (2026). The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro. Endocrine, 91(1), . https://doi.org/10.1007/s12020-026-04600-z
Chicago Style (17th ed.) CitationSM, Ferrari, et al. "The Pyrazolo[3,4-d]pyrimidine Derivative CLM24 Has an Antineoplastic Effect in Aggressive Dedifferentiated Thyroid Cancer in Vitro." Endocrine 91, no. 1 (2026). https://doi.org/10.1007/s12020-026-04600-z.
MLA (9th ed.) CitationSM, Ferrari, et al. "The Pyrazolo[3,4-d]pyrimidine Derivative CLM24 Has an Antineoplastic Effect in Aggressive Dedifferentiated Thyroid Cancer in Vitro." Endocrine, vol. 91, no. 1, 2026, https://doi.org/10.1007/s12020-026-04600-z.
Warning: These citations may not always be 100% accurate.
